Biomea Fusion outlined new insights into type 1 diabetes as a three-stage disease in a Piper Sandler expert webinar, highlighting earlier detection and interven

Biomea Fusion outlined new insights into type 1 diabetes as a three-stage disease in a Piper Sandler expert webinar, highlighting earlier detection and intervention. The update comes as the company advances Phase II testing of icovamenib after prior HbA1c durability data.